187 related articles for article (PubMed ID: 25135618)
21. [Apheresis in children: procedures and outcome].
Tummolo A; Colella V; Bellantuono R; Giordano M; Messina G; Puteo F; Sorino P; De Palo T
G Ital Nefrol; 2012; 29 Suppl 54():S125-9. PubMed ID: 22388843
[TBL] [Abstract][Full Text] [Related]
22. European Society of Pediatric Nephrology survey on current practice regarding recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
Bouts A; Veltkamp F; Tönshoff B; Vivarelli M;
Pediatr Transplant; 2019 May; 23(3):e13385. PubMed ID: 30825259
[TBL] [Abstract][Full Text] [Related]
23. [How to implement a complete apheresis program within a hemodialysis unit].
Maurizi-Balzan J; Jouve T; Naciri-Bennani H; Noble J; Tanoukhi K; Motte L; Malvezzi P; Rostaing L
Nephrol Ther; 2019 Nov; 15(6):439-447. PubMed ID: 31585841
[TBL] [Abstract][Full Text] [Related]
24. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
[TBL] [Abstract][Full Text] [Related]
25. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic plasma exchange in children: One center's experience.
Cortina G; Ojinaga V; Giner T; Riedl M; Waldegger S; Rosales A; Trojer R; Hofer J
J Clin Apher; 2017 Dec; 32(6):494-500. PubMed ID: 28485072
[TBL] [Abstract][Full Text] [Related]
27. The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
Yoshimura H; Yoshikawa Y; Noguchi Y; Totani T; Kusuta R; Shimazu K; Tanaka A; Komura K
J Clin Apher; 2023 Aug; 38(4):362-367. PubMed ID: 36367055
[TBL] [Abstract][Full Text] [Related]
28. Plasma exchange versus double filtration plasmapheresis in the treatment of Guillain-Barré syndrome.
Lyu RK; Chen WH; Hsieh ST
Ther Apher; 2002 Apr; 6(2):163-6. PubMed ID: 11982959
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic apheresis within immune-mediated neurological disorders: dosing and its effectiveness.
Klingele M; Allmendinger C; Thieme S; Baerens L; Fliser D; Jan B
Sci Rep; 2020 May; 10(1):7925. PubMed ID: 32404917
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic apheresis in kidney diseases: an updated review.
Chen YY; Sun X; Huang W; He FF; Zhang C
Ren Fail; 2022 Dec; 44(1):842-857. PubMed ID: 35723077
[TBL] [Abstract][Full Text] [Related]
31. Immunoadsorption in steroid-refractory multiple sclerosis: clinical experience in 60 patients.
Heigl F; Hettich R; Arendt R; Durner J; Koehler J; Mauch E
Atheroscler Suppl; 2013 Jan; 14(1):167-73. PubMed ID: 23357160
[TBL] [Abstract][Full Text] [Related]
32. Successful ABO incompatible renal transplantation following rituximab and DFPP after failed immunoadsorption.
Thalgahagoda S; Webb NJ; Roberts D; Birch A; Milford DV; Tavakoli A; Shenoy M
Pediatr Transplant; 2014 May; 18(3):E74-6. PubMed ID: 24483150
[TBL] [Abstract][Full Text] [Related]
33. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic plasma exchange in paediatric nephrology in Ireland.
Wildes DM; Devlin C; Costigan CS; Raftery T; Hensey C; Waldron M; Dolan N; Riordan M; Sweeney C; Stack M; Cotter M; Lynch B; Gorman KM; Awan A
Ir J Med Sci; 2024 Jun; 193(3):1589-1594. PubMed ID: 37940814
[TBL] [Abstract][Full Text] [Related]
35. Apheresis in treatment of acute inflammatory demyelinating disorders.
Mühlhausen J; Kitze B; Huppke P; Müller GA; Koziolek MJ
Atheroscler Suppl; 2015 May; 18():251-6. PubMed ID: 25936333
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic trial of low density lipoprotein apheresis (LDL-A) in conjunction with double filtration plasmapheresis (DFPP) in drug-resistant nephrotic syndrome due to focal glomerular sclerosis (FGS).
Tojo K; Sakai S; Miyahara T
Prog Clin Biol Res; 1990; 337():193-4. PubMed ID: 2191313
[No Abstract] [Full Text] [Related]
37. [Plasma exchange in nephrology: Indications and technique].
Ridel C; Kissling S; Mesnard L; Hertig A; Rondeau É
Nephrol Ther; 2017 Feb; 13(1):43-55. PubMed ID: 28110970
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic apheresis for renal disorders.
Sanchez AP; Ward DM
Semin Dial; 2012; 25(2):119-31. PubMed ID: 22428811
[TBL] [Abstract][Full Text] [Related]
39. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
40. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]